FDA Roundtable: E-Cigs Get Bureaucratic Ear
Published Date: 12/29/2025
Notice
Summary
The FDA is hosting a roundtable on February 10, 2026, to hear from small makers of electronic nicotine delivery systems (like e-cigarettes) about their experiences with the premarket approval process. They want to improve how these products are reviewed, focusing on safety, manufacturing, and health effects. If you’re involved in making or selling these products, now’s the time to share your thoughts and help shape future rules!
Analyzed Economic Effects
3 provisions identified: 2 benefits, 1 costs, 0 mixed.
FDA Roundtable for Small ENDS Makers
The FDA is holding a roundtable on February 10, 2026 to hear from small electronic nicotine delivery systems (ENDS) manufacturers about PMTA (premarket tobacco product application) submissions. Topics include product characterization, manufacturing controls, pharmacological profile (e.g., pharmacokinetic studies), studies of adult benefit (e.g., longitudinal cohort/RCT studies), and toxicological profile (e.g., estimated lifetime cancer risk).
Limited Panel Slots and Eligibility Rules
Registration to participate as a panelist is open to "small tobacco product manufacturers" (those with fewer than 350 employees) and is limited to 30 participants representing companies that have previously submitted an ENDS PMTA, including pending PMTAs. Registration is free and panelist registration must be submitted by January 27, 2026, 11:59 p.m. Eastern Time; only one person may represent each company and final eligibility is determined by FDA.
Public Docket, Comment Deadlines, and Remote Access
FDA established a public docket (Docket No. FDA-2025-N-7022) beginning December 29, 2025 for comments on the roundtable topics; electronic comments to be considered for the roundtable must be submitted by February 3, 2026, and all other electronic comments must be submitted by March 12, 2026 (regulations.gov will accept comments through 11:59 p.m. Eastern Time on March 12, 2026). The FDA accepts confidential written submissions under a two-copy process, will provide virtual viewing of the roundtable, and will post a transcript to regulations.gov when available; requests for disability accommodations must be emailed by February 3, 2026.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-11966 — Forms FDA 3542a and FDA 3542: Questions and Answers; Draft Guidance for Industry; Availability
The FDA just dropped a draft guide to help businesses fill out Forms FDA 3542a and FDA 3542 without confusion. If you submit these forms, this guide answers your top questions and makes the process smoother. You’ve got until August 14, 2026, to send in your feedback before the FDA finalizes the guide—no extra costs, just clearer steps!
2026-11998 — Amendment and Revocation of Organizational Information Regulations
The FDA is updating its rules to point everyone to its website for the latest contact and organizational info, ditching old, unnecessary regulations. This makes it easier for the public to find accurate info all in one place, starting June 15, 2026. If you interact with the FDA, expect smoother access with no extra costs or delays.
2026-11760 — Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Establishment, Maintenance, and Availability of Records; Additional Traceability Records for Certain Foods
The FDA is asking for approval to collect extra records from food businesses that handle certain high-risk foods. This helps track food sources quickly to keep everyone safe. Food companies should get ready to keep and share these new records, and comments on this plan are due by July 13, 2026.
2026-11762 — Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Procedures for the Safe Processing and Importing of Fish and Fishery Products
The FDA is asking for approval to keep collecting info from seafood processors and importers to make sure fish products are safe using a system called HACCP. This affects anyone who processes or imports fish and requires them to keep records showing they’re following safety rules. Comments on this plan are open until July 13, 2026, and there’s no new cost, just a continuation of current paperwork.
2026-11739 — Medical Devices; Immunology and Microbiology Devices; Classification of the Simple Point-of-Care Device to Directly Detect SARS-CoV-2 Viral Targets From Clinical Specimens in Near-Patient Settings
The FDA is officially putting simple COVID-19 rapid test devices into a safer, easier-to-manage category called Class II. This change means these tests can get to patients faster and with fewer hoops to jump through, while still making sure they work well and stay safe. Starting June 11, 2026, companies making these tests will follow new rules that help speed up innovation without extra costs.
2026-11740 — Medical Devices; Immunology and Microbiology Devices; Classification of the Spinal Muscular Atrophy Newborn Screening Test System
The FDA is officially putting the Spinal Muscular Atrophy (SMA) newborn screening test into class II, meaning it has special safety rules but fewer hurdles than the strictest category. This change helps make the test safer and easier to get to babies who need it, starting June 11, 2026, with the classification effective since November 2022. Labs and device makers will benefit from clearer rules and faster access, helping catch SMA early without extra costs or delays.
Previous / Next Documents
Previous: 2025-23843 — System Energy Resources Inc.; Grand Gulf Site Early Site Permit; Early Site Permit Renewal Application
System Energy Resources Inc., part of Entergy, wants to extend their Grand Gulf nuclear site permit for 20 more years beyond April 2027. They’ve asked the Nuclear Regulatory Commission to renew the permit without updating all the old info. This means the site can keep moving forward without big delays or extra costs right now.
Next: 2025-23852 — Over-the-Counter Monograph Drug User Fee Amendments-OTC Monograph Order Request Fee Rates for Fiscal Year 2026
Starting October 1, 2025, companies that make or request orders for over-the-counter (OTC) drugs will pay new fees to the FDA for fiscal year 2026. These fees help the FDA keep OTC drugs safe and effective. If you’re a manufacturer or submitter, get ready for updated costs that will last through September 30, 2026.